High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancer

High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancer

Background: Programmed cell death protein 1 (PD-1)/programmed cell death protein ligand 1 (PD-L1) immune checkpoint inhibitors have been approved for monotherapy of metastatic nonsmall cell lung cancer (mNSCLC) depending on tumour cells' PD-L1 expression. Pleural effusion is common in mNSCLC. T...

Full description

Bibliographic Details
Main Authors: Lars Hagmeyer, Stephan Schäfer, Marianne Engels, Anja Pietzke-Calcagnile, Marcel Treml, Simon-Dominik Herkenrath, Matthias Heldwein, Khosro Hekmat, Sandhya Matthes, Andreas Scheel, Jürgen Wolf, Reinhard Büttner, Winfried Randerath
Format: Article
Language:English
Published: European Respiratory Society 2021-03-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/7/1/00787-2020.full

Internet

http://openres.ersjournals.com/content/7/1/00787-2020.full

Similar Items